Limethason as a lipid microsphere preparation: An overview

Advanced Drug Delivery Reviews

Volumn 20, Issue 2-3, 1996, Pages 195-201

  Yokoyama, K ^a   Watanabe, M ^a  

^a Green Cross Company   (South Korea)

Author keywords

Anti inflammatory action; DDS; Dexamethasone palmitate; Liposteroid; Macrophage; Rheumatoid arthritis

Indexed keywords

CELLS; DISEASES; DRUG INTERACTIONS; DRUG THERAPY; LIPIDS;

CHRONIC INFLAMMATORY DISEASE; DEXAMETHASONE PALMITATE; DEXAMETHASONE PHOSPHATE; DRUG DELIVERY SYSTEM; LIMETHASON; LIPOSONES; RHEUMATOID ARTHRITIS; SYSTEMIC SIDE EFFECTS;

DRUG PRODUCTS;

CARRAGEENAN; DEXAMETHASONE; DEXAMETHASONE 21 PALMITATE; DEXAMETHASONE SODIUM PHOSPHATE; LIMETHASON; LIPID EMULSION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; DRUG SOLUBILITY; GRANULOMA; HEADACHE; HUMAN; INFLAMMATORY DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PHAGOCYTOSIS; PHARMACEUTICS; PRIORITY JOURNAL; PRURITUS; RAT; RHEUMATOID ARTHRITIS; STOMACH PAIN;

EID: 0030602826     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00122-N     Document Type: Review

References (14)

1. [1] Fendler, J.H. and Romero, A. (1977) Liposomes as drug cariers. Life Sci. 20, 1109.
2. [2] Weinstein, J.N. (1984) Liposomes as drug carriers in cancer therapy. Cancer Treat. Rep. 68, 127.
3. [3] Gregoriadis, G. (1984) Liposome technology. In: G. Gregoriadis and A.C. Allison (Eds), Liposomes in biological systems, Vols. I-III, Wiley, New York, NY.
4. [4] Shaw, I.H., Knight, C.G., Thomas, D.P.P. et al. (1979) Liposome-incorporated corticosteroid. I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane. Br. J. Exp. Pathol. 60, 142.
5. [5] Phillips, N.C., Thomas, D.P.P., Knight, C.G. et al. (1979) Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis. Ann. Rheum. Dis. 38, 553.
6. [6] Mizushima, Y., Hamano, T. and Yokoyama, K. (1982) Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann. Rheum. Dis. 41, 263.
7. [7] Koga, Y., Swanson, V.L. and Hayes, D.M. (1975) Hepatic 'intravenous fat pigment' in infants and children receiving lipid emulsion. J. Pedatr. Surg. 10, 641.
8. [8] Hallberg, D. (1985) Elimination of exogenous lipid from the bloodstream. Acta Physiol. Scand. 65, 254 (Suppl.).
9. [9] Mizushima, Y. (1985) Lipid microspheres as novel drug carriers. Drugs Exp. Clin. Res. 11, 595.
10. [10] Yokoyama, K., Okamoto, H., Watanabe, M. et al. (1985) Development of a corticosteroid incorporated in lipid micropheres (Liposteroid). Drugs Exp. Clin. Res. 11, 611.
11. [11] Iwai, M., Hamano, T., Arakawa, Y. et al. (1985) Pharmacokinetics of dexamethasone palmitate, a lipophilic pro-drug. Part 1. Distribution and excretion. Kiso to Rinsho (Lab. Clin.) 19, 4085.
12. [12] Iwai, M., Inoue, T., Arakawa, Y. et al. (1985) Pharmacokinetics of dexamethasone palmitate, a lipophilic prodrug. Part 2. Metabolism and identification of metabolite. Kiso to Rinsho (Lab. Clin.) 19, 4110.
13. [13] Ii, S., Okamoto, H., Yokoyama, K. et al. (1988) Comparative pharmacokinetic study of dexamethasone disodium phosphate in chronic rheumatoid arthritis patients. Yakuri to Chiryo (Basic Pharmacol. Ther.) 16, 865.
14. [14] Hoshi, K., Mizushima, Y., Shiokawa, Y. et al. (1985) Double-blind study with liposteroid in rheumatoid arthritis. Drugs Exp. Clin. Res. 11, 621.